GlucoTrack Stock Falls on Plans to Sell $3M Note

Dow Jones
09/13
 

By Katherine Hamilton

 

GlucoTrack shares fell after the company said it issued a $3.6 million convertible promissory note for $3 million.

The stock fell 8% to $9.75 in after-hours trading on Friday. At the close, it was down 98% this year.

The medical technology company said the note bears no interest and has an original issue discount of $600,000. It is an unsecured obligation and will rank equal in right of payment with GlucoTrack's existing and future unsecured debt.

The note will be due and payable 12 months after the issue date.

On Thursday, GlucoTrack entered into a purchase agreement with Sixth Borough Capital Fund establishing an equity line of credit. GlucoTrack has the right to sell Sixth Borough, and Sixth Borough is obligated to purchase up to $20 million of GlucoTrack's shares. GlucoTrack is required to use all of the proceeds from that sale to pay back the note.

 

Write to Katherine Hamilton at katherine.hamilton@wsj.com

 

(END) Dow Jones Newswires

September 12, 2025 18:26 ET (22:26 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10